Odyssey Health (ODYY) Long-Term Investments (2017 - 2025)
Odyssey Health's quarterly Long-Term Investments came in at $97149.0 in Q2 2025, down 99.28% year-on-year from $13.4 million in Q2 2024, and down 38.71% quarter-over-quarter from $158505.0 in Q1 2025.
Odyssey Health has reported Long-Term Investments for 3 years, with the latest figure at $97149.0 in Q2 2025.
- For the quarter ending Q2 2025, Long-Term Investments fell 99.28% year-over-year to $97149.0; the trailing twelve-month figure through Apr 2025 stood at $97149.0 (down 99.28% YoY), and the FY2024 full-year result was $529203.0, changed N/A from the prior year.
- Long-Term Investments for Q2 2025 stood at $97149.0, down from $158505.0 in the prior quarter.
- The five-year high for Long-Term Investments was $13.8 million in Q1 2024, with the low at $97149.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Odyssey Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 97,149.00 |
| Jan 31, 2025 | 158,505.00 |
| Oct 31, 2024 | 158,505.00 |
| Jul 31, 2024 | 529,203.00 |
| Apr 30, 2024 | 13.42 Mn |
| Jan 31, 2024 | 13.79 Mn |
| Oct 31, 2017 | 130,395.00 |
| Jul 31, 2017 | 107,157.00 |